Symptom severity is a major determinant of cannabis‐based products use among people with multiple sclerosis
Journal article published in 2023 by
Tangui Barré 
,
Damien Testa,
Melina Santos,
Fabienne Marcellin,
Perrine Roux,
Patrizia Carrieri,
Lise Radoszycki,
Camelia Protopopescu
,
Damien Testa,
Melina Santos,
Fabienne Marcellin,
Perrine Roux,
Patrizia Carrieri,
Lise Radoszycki,
Camelia Protopopescu
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 